Patient Guide: A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 56 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05526755
Status: ACTIVE_NOT_RECRUITING
Condition: Stage II-IIIB Non-small Cell Lung Carcinoma
Phase: PHASE2

Find a Study Location Near You

This study is available at 56 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Santa Rosa, California
  • Las Vegas, Nevada
  • White Plains, New York
  • • And 53 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily